TherapeuticsMD | TXMD - Ebitda

Prezzo Delle Azioni
2.05
Cambio Giornaliero
-0.02 -0.96%
Mensile
-6.81%
Annuale
45.40%
Q2 Previsione
2.03




Ebitda Cambiamento Data
AbbVie USD 5.37B 1.85B 2025-12
Alterity Therapeutics Limited AUD -7.72M 2.99M 2023-06
Cipla INR 12.55B 6.4B 2025-12
Clal Biotechnology ILS -5.3M 2.09M 2022-12
Compugen USD -7.89M 536K 2025-09
CSL USD 3.13B 1.17B 2025-12
Grifols EUR 482.04M 7.04M 2025-09
Novo Nordisk DKK 31.44B 6.84B 2025-09
Pfizer USD 5.99B 5.23B 2026-03
TherapeuticsMD USD -1.64M 700K 2023-09